Papanikolaou Katerina, Pehlivanidis Artemios
Professor of Child and Adolescent Psychiatry, National and Kapodistrian University of Athens.
Professor of Psychiatry, National and Kapodistrian University of Athens.
Psychiatriki. 2025 Sep 24;36(3):179-182. doi: 10.22365/jpsych.2025.023. Epub 2025 Sep 2.
Autism spectrum disorder (ASD) is classified among the neurodevelopmental disorders, which are described in the early chapters of DSM-51 and ICD-11.2 These disorders emerge in childhood, persist across the lifespan, and are characterized by deficits or diversities that affect personal, social, academic, and occupational functioning. Although the two major diagnostic systems have converged in terminology and criteria-with only minor differences in the categorization of co-occurring language and intellectual development disorders-Greece continues to rely on ICD-10, leading to difficulties in the consistent use of terminology among mental health professionals. The global rise in ASD prevalence over recent decades has been widely discussed, largely attributed to broadened diagnostic criteria and increased recognition in groups where autism was previously considered rare, such as women and individuals with milder symptoms. In the United States, current estimates suggest that 1 in 31 children may be diagnosed with ASD.3 In adults, the prevalence is consistently found to be lower. In Greece, the estimated prevalence based on diagnoses recorded by the Diagnostic, Assessment, and Counseling Centers (KEDASY) is 1.15%,4 while no epidemiological data exist for adults. The lifetime cost of care for an individual with autism may exceed 2 million USD.5 The socioeconomic burden in Greece has been exacerbated by the financial crisis, which had a more detrimental impact on families of individuals with autism than the COVID-19 pandemic.6 A critical gap in care has been documented internationally during the transition from adolescence to adulthood. Adults with autism frequently encounter the "double empathy problem," referring to reciprocal difficulties in their communication with neurotypical individuals. This, coupled with the stigma surrounding the diagnosis, often results in misjudgments regarding the abilities and needs of people with autism. Among adults with ASD, depression is the most prevalent and impairing co-occurring psychiatric disorder, often accompanied by anxiety disorders, both of which contribute to marked reductions in functioning, particularly during transitional periods.7-9 For the so-called "lost generation" of adults with autism-those with normal intelligence and relatively functional profiles whose diagnosis was missed earlier-an ASD diagnosis may resolve longstanding diagnostic uncertainty and explain treatment resistance in psychiatric disorders. Management of ASD and psychiatric comorbidities requires individualized treatment planning that integrates psychosocial interventions and targeted, when needed, pharmacological strategies. Multidisciplinary collaboration among professionals is essential, while active family involvement is of fundamental importance.10 In the era of precision medicine, its applicability to ASD depends on a comprehensive understanding of genetic, temperamental, and environmental factors, enabling personalized interventions that may enhance treatment effectiveness and reduce costs. Implementation of such approaches presupposes specialized training of mental health professionals. In Greece, structured training in adult autism for psychiatrists is limited or absent, resulting in delayed or inaccurate diagnoses, reduced access to appropriate services, and inadequate psychiatric care for adults with autism. While the curriculum of child psychiatry specialty provides training for autism in childhood, there is no continuity into adult psychiatry, even though adulthood spans the majority of life. The lack of training contributes to frequent misdiagnoses (particularly among women and individuals from the "lost generation"), inappropriate pharmacological treatments, and the mischaracterization of adults with autism 2 as "non-compliant." Consequently, many individuals with autism and their families are deprived of psychoeducation and necessary support. To address these shortcomings, we propose the integration of a dedicated module on adult ASD into the official psychiatry residency curriculum in Greece, alongside clinical training in autism-specialized services and acquisition of experience in the use of standardized assessment tools. Such measures are essential to improve diagnostic accuracy, ensure continuity of care, and enhance the quality of psychiatric services for adults with autism.
自闭症谱系障碍(ASD)被归类于神经发育障碍,这些障碍在《精神疾病诊断与统计手册》第5版1和《国际疾病分类》第11版2的早期章节中有描述。这些障碍在儿童期出现,持续终生,其特征是存在影响个人、社交、学业和职业功能的缺陷或差异。尽管这两个主要诊断系统在术语和标准上已经趋同——在共病的语言和智力发育障碍的分类上只有细微差别——但希腊仍在使用《国际疾病分类》第10版,这导致心理健康专业人员在术语的一致使用上存在困难。近几十年来,全球ASD患病率的上升受到了广泛讨论,这在很大程度上归因于诊断标准的拓宽以及对以前被认为自闭症罕见的群体(如女性和症状较轻的个体)的认识增加。在美国,目前的估计表明,每31名儿童中可能有1人被诊断为ASD。3在成年人中,患病率一直较低。在希腊,根据诊断、评估和咨询中心(KEDASY)记录的诊断情况估计患病率为1.15%,4而关于成年人的流行病学数据则不存在。自闭症患者一生的护理费用可能超过200万美元。5希腊的金融危机加剧了社会经济负担,金融危机对自闭症患者家庭的影响比对新冠肺炎疫情的影响更具破坏性。6国际上已经记录了从青春期到成年期护理方面的一个关键差距。成年自闭症患者经常遇到“双重同理心问题”,指的是他们与神经典型个体沟通时的相互困难。这一点,再加上围绕该诊断的污名化,往往导致对自闭症患者的能力和需求产生错误判断。在成年ASD患者中,抑郁症是最普遍且最具损害性的共病精神障碍,通常伴有焦虑症,这两种情况都会导致功能显著下降,尤其是在过渡时期。7 - 9对于所谓的成年自闭症“失落一代”——那些智力正常且功能相对良好但早期诊断被遗漏的人——ASD诊断可能解决长期存在的诊断不确定性,并解释精神疾病治疗抵抗的原因。ASD和精神共病的管理需要个性化的治疗计划,该计划整合心理社会干预措施,并在需要时采用有针对性的药物治疗策略。专业人员之间的多学科协作至关重要,而家庭的积极参与也至关重要。10在精准医学时代,其在ASD中的适用性取决于对遗传、气质和环境因素的全面理解,从而实现个性化干预,这可能提高治疗效果并降低成本。实施这些方法的前提是对心理健康专业人员进行专门培训。在希腊,针对精神科医生的成人自闭症结构化培训有限或不存在,这导致诊断延迟或不准确、获得适当服务的机会减少以及对成年自闭症患者的精神护理不足。虽然儿童精神病学专业课程提供了儿童自闭症方面的培训,但即使成年期占生命的大部分时间,也没有延续到成人精神病学。培训的缺乏导致频繁误诊(特别是在女性和“失落一代”个体中)、不适当的药物治疗以及将成年自闭症患者错误地描述为“不配合”。因此,许多自闭症患者及其家庭被剥夺了心理教育和必要的支持。为了解决这些缺点,我们建议在希腊官方精神科住院医师培训课程中纳入一个关于成人ASD的专门模块,同时进行自闭症专科服务的临床培训,并获取使用标准化评估工具的经验。这些措施对于提高诊断准确性、确保护理的连续性以及提高成年自闭症患者的精神服务质量至关重要。